Pallas Capital Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$34.8K	Buy	36,765 +557	+2%	+$527	﹤0.01%	838
2025 Q1	$16.7K	Buy	+36,208	New	+$16.7K	﹤0.01%	748